A new research review published in Advances in Hygiene and Experimental Medicine by researchers from the Jagiellonian University Medical College in Poland has found evidence in preclinical studies that cannabinoids inhibit tumor growth of various types. Some in vitro cell experiments and animal trials found phytocannabinoids, endocananbinoids, and synthetic cannabinoids all possess anti-tumor properties. Cannabinoids interact with cannabinoid receptors to stimulate chemical responses that inhibit cancer cell growth and destroy cancer cells, mainly through a process called apoptosis. The researchers state, “Leading from this there is a an obvious need to further explore cannabinoid associated molecular pathways making it possible to develop safe therapeutic drug agents for patients in the future.”
This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer.